Streetbeat News

Products Services

AKRO

ETNB

LLY

MDGL

SGMT

VKTX

On Wednesday, Madrigal Pharmaceuticals (MDGL) and Sagimet Biosciences (SGMT) stocks are trading lower following Eli Lilly's (LLY) presentation of positive Phase 2 trial results for tirzepatide in treating MASH at the EASL International Liver Congress 2024. Other companies working on MASH candidates include 89bio (ETNB), Akero Therapeutics (AKRO), and Viking Therapeutics (VKTX).

Portfolio Pulse from Vandana Singh

June 05, 2024 | 7:17 pm

TSLA

Tesla's FSD subscribers are canceling their subscriptions due to outdated software updates, leading to potential revenue loss for the company. The disconnect between Tesla's software rollout and customer expectations is causing dissatisfaction among users.

Portfolio Pulse from Benzinga EV Insights

June 05, 2024 | 7:16 pm

GLD

IAU

IVV

SPY

VOO

Ray Dalio, founder of Bridgewater Associates, warns of escalating U.S.-China tensions and the importance of diversification in investments. He highlights the risks of economic sanctions, internal U.S. conflicts, and global economic uncertainties. Dalio recommends diversifying across countries, currencies, and asset classes, and prefers equity over debt, with gold as a hedge.

Portfolio Pulse from Surbhi Jain

June 05, 2024 | 7:14 pm

SMCI

Super Micro Computer shares are trading higher after the company introduced a ready-to-deploy liquid-cooled AI data center.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 7:06 pm

NVOS

Novo Integrated Sciences' subsidiary, Acenzia, has been selected to participate in a $5.4 million project by Protein Industries Canada to develop plant-based protein products. Acenzia will invest $600,000, Protein Industries Canada $2.3 million, and two other partners $2.5 million.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 7:02 pm

IBIT

MSTR

RIOT

BlackRock's iShares Bitcoin Trust (IBIT) ETF has surged 50% since its launch in January 2024, amassing $20 billion in AUM. Kerrisdale Capital is long on IBIT and short on Riot Platforms (RIOT). Technical indicators suggest continued bullish momentum for IBIT.

Portfolio Pulse from Surbhi Jain

June 05, 2024 | 6:58 pm

MSFT

RBLX

Mobile games captured $90.4 billion in 2023, accounting for 49% of the global games market. Despite a 2% decline in overall consumer spending, in-app revenue for game apps increased by 6%. Top apps for consumer spending included Microsoft's Candy Crush Saga and Roblox Corp.'s Roblox. Advertising expenditure is projected to grow significantly in the coming years.

Portfolio Pulse from Franca Quarneti

June 05, 2024 | 6:55 pm

VIR

Vir Biotechnology Inc (NASDAQ:VIR) announced promising preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial, showing high virologic response rates and ALT normalization with tobevibart and elebsiran. The stock rose 18.1% following the news.

Portfolio Pulse from Vandana Singh

June 05, 2024 | 6:51 pm

AZN

BNTX

JNJ

MRNA

NVAX

PFE

FDA advisers have voted in favor of recommending a new Covid vaccine targeting the JN.1 lineage for the 2024-25 campaign.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 6:51 pm

AMD

INTC

NVDA

Bank of America analyst Vivek Arya reiterated a Buy rating and a $1,500 price target for Nvidia (NVDA) following positive investor meetings. Arya highlighted Nvidia's multi-year lead over competitors AMD and Intel, strong customer interest, and robust growth opportunities in AI and data centers.

Portfolio Pulse from Adam Eckert

June 05, 2024 | 6:49 pm